Comparison of HR011408 and NovoRapid ® in Subjects With Diabetics

Conditions: Diabetes Interventions: Drug: HR011408 injection; HR011408 injection Placebo; Drug: NovoRapid ®; HR011408 injection Placebo; Drug: HR011408 injection Placebo; HR011408 injection Sponsors: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials